ScholarIQanswers from OpenAlex

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia

PaperCitations, authors & open-access status

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia have?

ScholarIQcitation count

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia has 354 citations in the OpenAlex counts ScholarIQ stores.

When was Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia published?

ScholarIQyear

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia has 2003 year in the ScholarIQ index.

What is the open-access status of Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia?

ScholarIQoa status

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia has closed oa status in the ScholarIQ index.

What is the DOI of Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia?

ScholarIQdoi

The DOI for Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia is on the source record.

What is the PMID of Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia?

ScholarIQpmid

The PMID for Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia is on the source record.

What is the OpenAlex record for Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia?

ScholarIQopenalex

The OpenAlex for Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial